Table 2.
Surgical, non-surgical interventions and COVID-19 follow-up
| Emergency | High priority | Intermediate priority | Low priority | Total | COVID-19 testing in 7–14 days follow-up | |
|---|---|---|---|---|---|---|
| Surgeries | ||||||
| Radical nephrectomy | ||||||
| Open | 2 | 2 | 4 | Negative | ||
| Laparoscopic | 1 | 1 | Negative | |||
| Radical cystectomy + IC | 1 | 1 | Negative | |||
| Robotic radical prostatectomy | 1 | 1 | Negative | |||
| Radical orchiectomy | 1 | 1 | Negative | |||
| TUR-bladder | 1 | 10 | 11 | Negative | ||
| TRUS prostate biopsy | 2 | 2 | Negative | |||
| Transvesical prostatectomy | 1 | 1 | Negative | |||
| RIRS | 1 | 8 | 9 | Negative | ||
| Ureterorenoscopy | 7 | 4 | 4 | 15 | Negative | |
| Double-J removal | 6 | 6 | Negative | |||
| Double-J stenting | 4 | 4 | Negative | |||
| Testicular exploration | 1 | 1 | Negative | |||
| Nephrostomy insertion | 4 | 4 | Negative | |||
| Internal urethrotomy | 1 | 1 | Negative | |||
| Botox application | 1 | 1 | Negative | |||
| Penile fracture repair | 1 | 1 | Negative | |||
| Sacral neuromodulation | 1 | 1 | Negative | |||
| Total | 18 | 15 | 4 | 28 | 65 | |
| Non-surgical procedures | ||||||
| Urodynamics | 3 | 3 | Negative | |||
| Uroflowmetry | 64 | 64 | Negative | |||
| Urethral catheterization | 20 | 20 | Negative | |||
| ESWL | 4 | 4 | Negative | |||
| BCG-session | 4 | 4 | Negative | |||
| Total | 20 | 75 | 95 | |||
IC ileal conduit, RIRS retrograde intrarenal surgery, TUR transurethral resection, TRUS transrectal ultrasonography, ESWL extracorporeal shock wave lithotripsy, BCG Bacillus Calmette–Guérin